Fran Cogen, MD, joins Diana Isaacs, PharmD, BCPS, BC-ADM, CDCES, and Natalie Bellini, DNP, FNP-BC, on this MEDcast episode to stress the significance of early detection for type 1 diabetes. The conversation covers screening protocols and options, as well as emerging treatments that can delay the onset of the disease.
Drs Diana Isaacs and Natalie Bellini summarize the key takeaways on screening for pediatric and adult-onset type 1 diabetes and strategies to improve screening.
This feature articles commemorates the 10-year anniversary of the FDA's first approval of an SGLT2 inhibitor on March 29, 2013 and provides a snapshot at the class's ascent into the treatment algorithms and guidelines for type 2 diabetes, heart failure, and chronic kidney disease.
In this episode, hosts celebrate the 10-year anniversary of the approval of the first SGLT2 inhibitor, discuss announcements related to insulin pricing, and take a deep dive into 24-week data from the MOMENTUM trial.
The greater the degree of automation in the devices worn by patients with type 1 diabetes participating in the T1D Exchange, the more likely they were to achieve A1c targets and avoid severe hypoglycemia.